NCT03317483View on ClinicalTrials.gov

DEB-TACE Treatment in 367 Liver Cancer Patients

CompletedOBSERVATIONAL
Enrollment

367

Participants

Timeline

Start Date

November 12, 2015

Primary Completion Date

November 4, 2016

Study Completion Date

December 28, 2016

Conditions
Liver Cancer
All Listed Sponsors
lead

Zhejiang Cancer Hospital

OTHER

NCT03317483 - DEB-TACE Treatment in 367 Liver Cancer Patients | Biotech Hunter | Biotech Hunter